Glutaminyl Cyclase Inhibitor 1

CAS No. 2110449-60-8

Glutaminyl Cyclase Inhibitor 1( —— )

Catalog No. M32941 CAS No. 2110449-60-8

Glutaminyl Cyclase Inhibitor 1, a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM, can be utilized for studying neurological disorders.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 126 In Stock
5MG 116 In Stock
10MG 187 In Stock
25MG 345 In Stock
50MG 551 In Stock
100MG 927 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glutaminyl Cyclase Inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Glutaminyl Cyclase Inhibitor 1, a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM, can be utilized for studying neurological disorders.
  • Description
    Glutaminyl Cyclase Inhibitor 1 is a glutaminyl cyclase inhibitor with an IC50 of 0.5 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Guanylate Cyclase
  • Recptor
    Guanylate cyclase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2110449-60-8
  • Formula Weight
    369.43
  • Molecular Formula
    C21H24FN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?Ethanol : 100 mg/mL (270.69 mM; Ultrasonic) DMSO : 83.33 mg/mL (225.56 mM; Ultrasonic )
  • SMILES
    COc1ccc(cc1OC)-c1cccc(F)c1NCCCn1cnc(C)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Li M, et al. Synthesis and Evaluation of Diphenyl Conjugated Imidazole Derivatives as Potential Glutaminyl Cyclase Inhibitors for Treatment of Alzheimer's Disease. J Med Chem. 2017 Aug 10;60(15):6664-6677.?
molnova catalog
related products
  • Indusatumab

    Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody utilized for synthesizing antibody-drug conjugates.

  • BAY 41-8543

    BAY 41-8543 is an NO-independent sGC (soluble guanylyl cyclase) stimulator, inhibits collagen-mediated aggregation in washed human platelets (IC50=90 nM).

  • MCUF-651

    MCUF-651 is a guanylyl cyclase A receptor positive allosteric modulators, EC50=0.45 μM.